MARKET

CYPH

CYPH

Cypherpunk Technologies Inc
NASDAQ
0.8128
+0.1626
+25.01%
Pre Market: 0.7999 -0.0129 -1.59% 09:14 06/16 EDT
OPEN
0.8000
PREV CLOSE
0.6502
HIGH
0.8500
LOW
0.7571
VOLUME
99.94K
TURNOVER
0
52 WEEK HIGH
3.700
52 WEEK LOW
0.2323
MARKET CAP
86.53M
P/E (TTM)
-1.1836
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 1d ago
10 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 1d ago
Weekly Report: what happened at CYPH last week (0608-0612)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 06/08 17:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 06/08 12:06
Weekly Report: what happened at CYPH last week (0601-0605)?
Weekly Report · 06/08 09:32
BUZZ-U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
Reuters · 06/05 18:02
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 06/05 17:05
More
About CYPH
Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.

Webull offers Cypherpunk Technologies Inc stock information, including NASDAQ: CYPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CYPH stock methods without spending real money on the virtual paper trading platform.